Top compounds associated with response to GCSH


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.18 5e-07
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 8e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.17 1e-05
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 9e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.14 0.0001
Download CSV